Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission

Ying Sun Xiang Ying Sun, L. Edvinsson, H. Yoo, Claes R Wahlestedt, T. Hedner

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The vascular effects of myo-inositol and a series of n-myo-inositol phosphate derivatives: D-myo inositol-1-monophosphate (Ins[1]P1), D-myo- inositol-2-monophosphate (Ins[2]P1), D-myo-inositol-1, 2-biphosphate (Ins[1,2]P2), D-myo-inositol-1,2,6-trisphosphate (Ins[1,2,6]P3, α- trinositol; PP56), D-myoinositol-1,2,5,6-tetraphosphate (Ins[1,2,5,6]P4), and D-myo-inositol-1,2,3,4,5,6-hexa-phosphate (InsP6, phytic acid) were studied in binding assays in rat heart membranes, in vitro in isolated guinea pig basilar artery, and in vivo in pithed rats. In binding assays in rat heart membranes, Ins[1,2,6]P3, Ins[1,2,5,6]P4, and InsP6, displaced the binding of [3H]α-trinositol [3H][1,2,6]P3). In the isolated guinea pig basilar artery, Ins[1,2]P2 and Ins[1,2,6]P3 inhibited the contractile effects of exogenous neuropeptide Y (NPY) in the concentration range of 10 - 8-10 -6 M. In pithed Sprague-Dawley rats, Ins[1,2,6]P3 inhibited the NPY- induced pressor response in the dose range [2 mg/kg (3.8 μmol/kg) combined with an infusion of 20 mg/kg/h (38 μmol/kg/h) for 30 min] in which no inhibitory effects on the pressor responses were elicited by preganglionic nerve stimulation (PNS) or a bolus injection of phenylephrine (Phe). Ins[1,2]P2 had only slight NPY inhibitory effects in vivo. We conclude that selected inositol derivatives may inhibit the vasopressor effects to NPY in vitro and in vivo. In particular, Ins[1,2,6]P3, which most readily inhibited the NPY-induced pressor response in vivo, may represent a new class of synthetic nonpeptide drugs, which may inhibit the vascular effects of NPY without binding to the NPY receptor itself.

Original languageEnglish
Pages (from-to)696-704
Number of pages9
JournalJournal of Cardiovascular Pharmacology
Volume25
Issue number5
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Inositol Phosphates
Neuropeptide Y
Inositol
Basilar Artery
Blood Vessels
Guinea Pigs
Neuropeptide Y Receptors
Phytic Acid
Membranes
Phenylephrine
Sprague Dawley Rats
Phosphates
Injections
Pharmaceutical Preparations

Keywords

  • Cardiac membranes
  • Guinea pig basilar artery
  • Inositol 1,2,6- trisphosphate (α-trinositol)
  • Pithed rat
  • Structure activity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission. / Xiang Ying Sun, Ying Sun; Edvinsson, L.; Yoo, H.; Wahlestedt, Claes R; Hedner, T.

In: Journal of Cardiovascular Pharmacology, Vol. 25, No. 5, 01.01.1995, p. 696-704.

Research output: Contribution to journalArticle

Xiang Ying Sun, Ying Sun ; Edvinsson, L. ; Yoo, H. ; Wahlestedt, Claes R ; Hedner, T. / Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission. In: Journal of Cardiovascular Pharmacology. 1995 ; Vol. 25, No. 5. pp. 696-704.
@article{9d4520dbff524294b27c1f7ffd27c294,
title = "Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission",
abstract = "The vascular effects of myo-inositol and a series of n-myo-inositol phosphate derivatives: D-myo inositol-1-monophosphate (Ins[1]P1), D-myo- inositol-2-monophosphate (Ins[2]P1), D-myo-inositol-1, 2-biphosphate (Ins[1,2]P2), D-myo-inositol-1,2,6-trisphosphate (Ins[1,2,6]P3, α- trinositol; PP56), D-myoinositol-1,2,5,6-tetraphosphate (Ins[1,2,5,6]P4), and D-myo-inositol-1,2,3,4,5,6-hexa-phosphate (InsP6, phytic acid) were studied in binding assays in rat heart membranes, in vitro in isolated guinea pig basilar artery, and in vivo in pithed rats. In binding assays in rat heart membranes, Ins[1,2,6]P3, Ins[1,2,5,6]P4, and InsP6, displaced the binding of [3H]α-trinositol [3H][1,2,6]P3). In the isolated guinea pig basilar artery, Ins[1,2]P2 and Ins[1,2,6]P3 inhibited the contractile effects of exogenous neuropeptide Y (NPY) in the concentration range of 10 - 8-10 -6 M. In pithed Sprague-Dawley rats, Ins[1,2,6]P3 inhibited the NPY- induced pressor response in the dose range [2 mg/kg (3.8 μmol/kg) combined with an infusion of 20 mg/kg/h (38 μmol/kg/h) for 30 min] in which no inhibitory effects on the pressor responses were elicited by preganglionic nerve stimulation (PNS) or a bolus injection of phenylephrine (Phe). Ins[1,2]P2 had only slight NPY inhibitory effects in vivo. We conclude that selected inositol derivatives may inhibit the vasopressor effects to NPY in vitro and in vivo. In particular, Ins[1,2,6]P3, which most readily inhibited the NPY-induced pressor response in vivo, may represent a new class of synthetic nonpeptide drugs, which may inhibit the vascular effects of NPY without binding to the NPY receptor itself.",
keywords = "Cardiac membranes, Guinea pig basilar artery, Inositol 1,2,6- trisphosphate (α-trinositol), Pithed rat, Structure activity",
author = "{Xiang Ying Sun}, {Ying Sun} and L. Edvinsson and H. Yoo and Wahlestedt, {Claes R} and T. Hedner",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "25",
pages = "696--704",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission

AU - Xiang Ying Sun, Ying Sun

AU - Edvinsson, L.

AU - Yoo, H.

AU - Wahlestedt, Claes R

AU - Hedner, T.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The vascular effects of myo-inositol and a series of n-myo-inositol phosphate derivatives: D-myo inositol-1-monophosphate (Ins[1]P1), D-myo- inositol-2-monophosphate (Ins[2]P1), D-myo-inositol-1, 2-biphosphate (Ins[1,2]P2), D-myo-inositol-1,2,6-trisphosphate (Ins[1,2,6]P3, α- trinositol; PP56), D-myoinositol-1,2,5,6-tetraphosphate (Ins[1,2,5,6]P4), and D-myo-inositol-1,2,3,4,5,6-hexa-phosphate (InsP6, phytic acid) were studied in binding assays in rat heart membranes, in vitro in isolated guinea pig basilar artery, and in vivo in pithed rats. In binding assays in rat heart membranes, Ins[1,2,6]P3, Ins[1,2,5,6]P4, and InsP6, displaced the binding of [3H]α-trinositol [3H][1,2,6]P3). In the isolated guinea pig basilar artery, Ins[1,2]P2 and Ins[1,2,6]P3 inhibited the contractile effects of exogenous neuropeptide Y (NPY) in the concentration range of 10 - 8-10 -6 M. In pithed Sprague-Dawley rats, Ins[1,2,6]P3 inhibited the NPY- induced pressor response in the dose range [2 mg/kg (3.8 μmol/kg) combined with an infusion of 20 mg/kg/h (38 μmol/kg/h) for 30 min] in which no inhibitory effects on the pressor responses were elicited by preganglionic nerve stimulation (PNS) or a bolus injection of phenylephrine (Phe). Ins[1,2]P2 had only slight NPY inhibitory effects in vivo. We conclude that selected inositol derivatives may inhibit the vasopressor effects to NPY in vitro and in vivo. In particular, Ins[1,2,6]P3, which most readily inhibited the NPY-induced pressor response in vivo, may represent a new class of synthetic nonpeptide drugs, which may inhibit the vascular effects of NPY without binding to the NPY receptor itself.

AB - The vascular effects of myo-inositol and a series of n-myo-inositol phosphate derivatives: D-myo inositol-1-monophosphate (Ins[1]P1), D-myo- inositol-2-monophosphate (Ins[2]P1), D-myo-inositol-1, 2-biphosphate (Ins[1,2]P2), D-myo-inositol-1,2,6-trisphosphate (Ins[1,2,6]P3, α- trinositol; PP56), D-myoinositol-1,2,5,6-tetraphosphate (Ins[1,2,5,6]P4), and D-myo-inositol-1,2,3,4,5,6-hexa-phosphate (InsP6, phytic acid) were studied in binding assays in rat heart membranes, in vitro in isolated guinea pig basilar artery, and in vivo in pithed rats. In binding assays in rat heart membranes, Ins[1,2,6]P3, Ins[1,2,5,6]P4, and InsP6, displaced the binding of [3H]α-trinositol [3H][1,2,6]P3). In the isolated guinea pig basilar artery, Ins[1,2]P2 and Ins[1,2,6]P3 inhibited the contractile effects of exogenous neuropeptide Y (NPY) in the concentration range of 10 - 8-10 -6 M. In pithed Sprague-Dawley rats, Ins[1,2,6]P3 inhibited the NPY- induced pressor response in the dose range [2 mg/kg (3.8 μmol/kg) combined with an infusion of 20 mg/kg/h (38 μmol/kg/h) for 30 min] in which no inhibitory effects on the pressor responses were elicited by preganglionic nerve stimulation (PNS) or a bolus injection of phenylephrine (Phe). Ins[1,2]P2 had only slight NPY inhibitory effects in vivo. We conclude that selected inositol derivatives may inhibit the vasopressor effects to NPY in vitro and in vivo. In particular, Ins[1,2,6]P3, which most readily inhibited the NPY-induced pressor response in vivo, may represent a new class of synthetic nonpeptide drugs, which may inhibit the vascular effects of NPY without binding to the NPY receptor itself.

KW - Cardiac membranes

KW - Guinea pig basilar artery

KW - Inositol 1,2,6- trisphosphate (α-trinositol)

KW - Pithed rat

KW - Structure activity

UR - http://www.scopus.com/inward/record.url?scp=0028948193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028948193&partnerID=8YFLogxK

M3 - Article

C2 - 7630147

AN - SCOPUS:0028948193

VL - 25

SP - 696

EP - 704

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 5

ER -